Pharmaceutical Biotechnology Experts are professionals who apply advanced biological and biotechnological methods to develop new drugs and therapies. They focus on the use of living organisms, cells, and biological processes to create biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. By harnessing the power of biotechnology, these experts are pioneering new treatments for complex diseases like cancer, diabetes, and genetic disorders. Their work plays a pivotal role in developing biologic therapies that offer personalized and targeted treatment options, improving the effectiveness and safety of healthcare. With the integration of cutting-edge technologies, these experts are at the forefront of developing next-generation treatments that can significantly alter disease progression.
These are work at the intersection of biology, chemistry, and pharmacology, using tools such as genetic engineering, cell culture, and gene editing techniques like CRISPR. Their primary goal is to optimize the production of high-quality biologic drugs while ensuring they are safe, scalable, and cost-effective for widespread use. Pharmaceutical biotechnology experts also navigate the complexities of regulatory approval processes, ensuring that new therapies meet the necessary standards for patient safety and efficacy. With the rise of biologic drugs in modern medicine, these professionals are critical in driving the innovation that addresses unmet medical needs and helps transform the future of healthcare.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia